title: The Cost Effectiveness of LAA Exclusion.
abstract: Left atrial appendage (LAA) exclusion strategies are increasingly utilized for stroke prevention in lieu of oral anticoagulants. Reductions in bleeding risk and long-term compliance issues bundled with comparable stroke prevention benefits have made these interventions increasingly attractive. Unfortunately, healthcare funding remains limited. Comparative cost economic analyses are therefore critical in optimizing resource allocation. In this review we seek to discourse the cost economics analysis of LAA exclusion over available therapeutic alternatives (warfarin and the new oral anticoagulants (NOACs)). .
authors.affiliation: Methodist DeBakey Heart and Vascular Center and Methodist Hospital Research Institute, The Methodist Hospital, Houston, Texas.
authors.forename: Bahij
authors.initials: B
authors.lastname: Kreidieh
authors.affiliation: Methodist DeBakey Heart and Vascular Center and Methodist Hospital Research Institute, The Methodist Hospital, Houston, Texas.
authors.forename: Moisés Rodríguez
authors.initials: MR
authors.lastname: Mañero
authors.affiliation: Methodist DeBakey Heart and Vascular Center and Methodist Hospital Research Institute, The Methodist Hospital, Houston, Texas.
authors.forename: Sergio H Ibarra
authors.initials: SH
authors.lastname: Cortez
authors.affiliation: Methodist DeBakey Heart and Vascular Center and Methodist Hospital Research Institute, The Methodist Hospital, Houston, Texas.
authors.forename: Paul
authors.initials: P
authors.lastname: Schurmann
authors.affiliation: Methodist DeBakey Heart and Vascular Center and Methodist Hospital Research Institute, The Methodist Hospital, Houston, Texas.
authors.forename: Miguel
authors.initials: M
authors.lastname: Valderrábano
keywords: Cost Effectiveness; Left Atrial Appendage Exclusion; Watchman,Lariat